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Abstract 
 Blood specimens are labeled at the time of acquisition in order to identify and match the 
specimen, label, and order to the patient.  While the labeling process is not new, it is frequently 
laden with errors (Brown, Smith, & Sherfy, 2011).  Wrong blood in tube (WBIT) poses 
significant risk.  Multiple factors contribute to mislabeling errors, including lax policies, limited 
technological solutions, decentralized labeling processes, multi-tasking, distraction from the 
clinician, and insufficient education and training of staff.  To reduce blood specimen labeling 
errors, a large academic medical center implemented an innovative technological solution for 
specimen labeling that integrates patient identification, physician order, and laboratory specimen 
identification through barcode technology that interfaces with the electronic medical record at 
the point of care.  A failure mode, effects and critical analysis (FMECA) were completed to 
assess for system failure points, and to design workflow prior to training staff.  Four failure 
points were identified and eliminated through workflow adjustments with the new system.  Staff 
training utilizing simulation highlighted system safety points.  This quality improvement process 
applied across adult and pediatric acute and critical care units provided dramatic reductions in 
blood specimen labeling errors pre/post intervention. 
 
Keywords:  specimen labeling, error, failure modes, effects and critical analysis, (FMECA), simulation, wrong 
blood in tube (WBIT), patient safety. 
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Specimen Labeling Improvement Project:  SLIP 
Blood specimens are labeled at the time of acquisition in order to identify and match the 
specimen, label, and order to the patient.  While the labeling process is not new, it is frequently 
laden with errors (Brown, Smith, & Sherfy, 2011).  Multiple factors contribute to mislabeling 
errors, including lax policies, limited technological solutions, multi-tasking/distraction from the 
clinician, and insufficient education and training of staff.  Technological advances to support 
blood specimen labeling are expensive and have not been widely implemented.  The potential 
consequences of a mislabeled specimen include misdiagnosis, potential miss-transfusion, patient 
discomfort in obtaining a new specimen, delays in treatment, and poor utilization of expensive 
resources.   
Among the most serious labeling errors is wrong blood in tube (WBIT).  Mislabeling pre-
blood transfusion specimens, resulting in WBIT, is an international practice issue and well 
documented in the literature to be the most common cause of an adverse blood transfusion 
reaction (Ansari & Szallasi, 2011).  WBIT is usually discovered when a patient’s blood sample is 
found to have an ABO/Rh type that does not match the ABO/Rh type in that person’s historic 
Blood Bank file.  According to the 2011 National Blood Collection and Utilization Survey 
Report (2011), hospitals reported 182,000 sample collection errors.  Of these errors, 5,747 were 
WBIT errors (3.2% of sample collection errors) (2011 NBCUS Report, 2011).  
In various settings, a number of process improvement measures have been implemented 
in an effort to reduce mislabeling errors specifically for specimens’ utilized pre-blood 
transfusion.  The most frequently reported interventions to reduce specimen-labeling error are 
strict policies (in clinical setting and Blood Bank), education, and two person checks.  However, 
these interventions have not resulted in the elimination of error.  The persistence of error is 
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attributed primarily to human factors (Rees, Stevens, Mikelsons, & Darcy, 2012).  Those 
facilities that have automated the process of patient identification (barcoding) with label printers 
at the bedside, integrating physician order entry, have experienced the most significant reduction 
in labeling error.  Brown et al. (2011) reports a “label error reduction from 103 to 8 per year 
(p<.001)” with implementation of barcode technology and bedside printers (p.13).  
Consistent with reports of specimen labeling error in the literature, blood specimen 
labeling errors are prevalent at one large academic medical center (medical center).  Efforts to 
reduce mislabeled specimens by means of sharing error data with management have not achieved 
desired results.  Implementation of strict policies with accountability, education of clinicians, 
technology at the point of care, and systems approaches to reduce labeling error is all strategies 
supported in the literature (Evanovitch, 2012).  A specimen labeling improvement project (SLIP) 
was undertaken at the medical center utilizing known strategies for reducing blood specimen 
mislabeling with implementation of an innovative point of care specimen collection management 
system (SCMS) integrated with a broader laboratory information system (LIS).   
Background Knowledge 
 The setting for this project is a large (700+ bed), non-profit, tertiary/quaternary academic 
medical center located on the West Coast, adjacent to medical, nursing and dental schools.  The 
patient population is diverse and complex.  Laboratory tests approximate on average 448,000 
tests per month.  Blood transfusions approximate 27,000 units of blood per year and each patient 
must be typed and cross-matched to receive a unit of blood (Laboratory Medical Director, 
personal communication, August 28, 2014).  In 2012, an electronic medical record (EMR) was 
implemented across the medical center that includes physician order entry (CPOE) and barcode 
technology for medication administration.  At the time of the EMR rollout, the Laboratory did 
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not have an information system that interfaced with the EMR.  Integration of laboratory 
information was thought to be critical, not only for access to patient laboratory values but also 
because all pre-analytic blood specimen processes were manual, requiring paper requisitions and 
generic handwritten or centrally printed labels.  Subsequently, the Laboratory implemented a 
new Laboratory Information System (LIS) with interface to the EMR.  Included in the LIS was a 
software system providing the ability to integrate a provider order for specimens with patient 
identification, as well as specimen label printing at the point of care.  Prior to the LIS, Blood 
Bank and Laboratory medical directors would send error data to nurse managers, encouraging 
them to follow-up with staff on accurate specimen labeling.  Initially, senior nurse leaders were 
not included in the specimen label error data distribution and therefore, were not aware of the 
issue, or the challenges experienced by staff to label specimens correctly.     
 According to the Federal Drug Administration (FDA) report on Fatalities Following 
Blood Collection and Transfusion (2012), the blood supply is safer today than at any time in 
history due to advances in donor screening, improved testing, automated data systems, and 
changes in transfusion medicine practices (FDA, 2012).  Yet, a patient is more likely to have an 
adverse blood transfusion reaction related to a mislabeled specimen (WBIT) than a viral 
infection (Dzik et al., 2003; Brown, Smith, & Sherfy, 2011).  In fiscal year 2012, two of the 65 
total transfusion-related deaths reported to the FDA were attributed to labeling errors (FDA, 
2012).  Institutions that measure their WBIT rates have reported that mislabeled specimens 
account for their highest error rate and these errors are most commonly detected in the 
laboratory.  Type and cross match blood specimens are compared to a patient’s previous 
documented blood type to ascertain a match.  According to Ansari and Szallasi (2011), the 
estimated “raw” WBIT rate published in the literature is 1:2262 samples (p. 298).  The reported 
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rate of 1:2262 samples is a reduction based on an international study conducted in 2003 reporting 
that 1 in every 165 samples was mislabeled (Dzik et al., 2003).  Tondon et al. (2010) conducted a 
prospective data analysis and found that blood sample labeling errors were due to failure to label 
at the bedside or labeling two or more samples at the same time by the same phlebotomist.  The 
authors proposed a strict policy of rejecting any mislabeled specimen (Tondon, Pandey, Mickey, 
& Chaudhary, 2010).  This approach does not account for those patients that have not been 
previously transfused and therefore may not have a documented blood type for lab to recognize a 
mislabeled specimen (WBIT).  Vuk et al. (2014) report “silent WBIT cases” are unrecognized 
when two donors have the same blood type during cross match (p. 1201).  Dzik et al. (2008) 
proposed a statistical process control (SPC) method as a means to reduce labeling errors through 
use of data control charts.  A similar approach was attempted without success at the medical 
center.   
 The PROBE-TM study (2007) attempted to utilize a simple intervention in the form of a 
barrier-warning label on blood bags reminding staff to check the patient’s wristband prior to 
transfusion.  The investigators concluded that this approach did not improve patient 
identification but suggested the robust study design could be applied to investigate other 
interventions (Murphy et al., 2007).  The most promising method for reducing blood sample 
labeling errors was reported by Brown et al. (2011) utilizing barcode technology, order 
integration and bedside printers.  The authors noted a statistically significant reduction in number 
of labeling errors, from103 to eight per year (p<.001) (p. 13).  Although this technology is 
expensive, most medical centers moving to an EMR have either implemented or plan to 
implement barcode technology for medication administration.  Barcode technology for patient 
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identification and bedside printers for specimen labels could significantly reduce WBIT errors 
and other blood specimen label errors.   
 Technology and methods to reduce labeling errors has not caught up to the safety of the 
blood itself.  Understanding and reducing human factor error in the clinical setting through the 
use of education, policy and technology is essential to eliminating labeling error and reducing the 
possibility of an ABO incompatible transfusion, which can result in significant morbidity and 
mortality.  According to Reason (2000), “the basic premise in the system approach is that 
humans are fallible and errors are to be expected, even in the best organizations.  Errors are seen 
as consequences rather than causes, having their origins not so much in the perversity of human 
nature as in ‘upstream’ systemic factors” (Reason, 2000, p. 768).   
Local Problem 
 The process for labeling specimens at the medical center following implementation of an 
EMR, but prior to the SLIP project, was laborious and carried with it a high risk for error.  
Specimen labeling errors occurred with all specimen types.  For the purposes of this project, the 
focus was specific to blood specimens.  A clinician would obtain an order for a blood specimen, 
pick up the paper requisition from the printer (mixed in with other requisitions) at the central 
station, gather phlebotomy supplies (tubes, needles, tourniquet) and go to the patient room in 
order to obtain a blood specimen.  Labels were obtained at the central desk (mixed with other 
labels) after the specimen was drawn.  Distraction, label mix-ups, wrong requisitions, and lack of 
proper identification of the patient could all contribute to labeling errors.  The Joint 
Commission’s number one National Patient Safety Goal for 2014 continues to be “reliably 
identify the patient”, “use at least two patient identifiers when collecting blood samples and other 
specimens”, and “label containers used for blood and other specimens in the presence of the 
SPECIMEN LABELING IMPROVEMENT PROJECT:  SLIP 11 
 
patient” (The Joint Commission, 2014, p. 1).  Additionally, in a study at University of 
Wisconsin, Rees et al. (2012) found that one frequently occurring specimen labeling error had to 
do with obtaining labels from a department printer rather than at the bedside, resulting in staff 
picking up labels for the wrong patient.  The labeling system at the medical center seemed 
designed to ignore the Joint Commission standards and to replicate errors found in another large 
academic medical center.      
 Blood Bank and Laboratory have been acutely aware of specimen labeling errors.   
Incident report data reviewed at nurse quality meetings highlighted labeling errors.  When the 
Chief Nursing Officer became aware of the problem she sent out several memos to all nursing 
staff outlining the important steps of labeling correctly.  Label error criteria were categorized by 
Blood Bank (see Figure 1.0 – Blood Bank Error Criteria). 
Figure 1.0.  Blood Bank Error Criteria 
Category                  Errors Included 
Near Miss Specimen Errors  
  
Includes serious specimen errors, 
which could potentially lead to issuing 
a wrong unit of blood to a patient.  
These include the following types of 
errors: 
  
  
  
 
 
 
1. Wrong Blood in Tube – Usually discovered when a 
patient’s sample is found to have an ABO/Rh type that 
does not match the ABO/Rh type in that patient’s 
historic Blood Bank file.   
2. Discrepancy between patient information (name and 
MRN) on specimen and requisition. 
3. Patient information on specimen is incorrect or missing 
4. Patient information on requisition is incorrect or missing 
5. Unlabeled 
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Specimen Collection Problems  
  
Includes other types of specimen 
problems, which prevent Blood Bank 
from testing a sample.  These 
specimen problems require the patient 
to be drawn again and take up extra 
nursing and Blood Bank staff time to 
manage.   
  
  
1. Unsigned specimens – per AABB Standards (CA law) 
Blood Bank must be able to identify the individual who 
drew the sample.  Thus Blood Bank requires all samples 
to have legible name/signature of phlebotomist (or 5 
digit MD #). 
2. Hemolyzed specimens 
3. Phlebotomist signature on tube is illegible 
4. Requisition missing 
5. Quantity Not Sufficient (QNS) 
6. No specimen 
7. Wrong tube type 
8. Empty tube 
9. Other (i.e. date of draw missing, Draw Date/Time the 
same for 2
nd
 ABO/Rh sample, diluted with saline, 
spillage)        
(Medical Center Transfusion Medicine, 2012). 
In 2013, there were 117 near miss labeling events and 612 collection problems (see Appendices 
A and B-Blood Bank Specimen Labeling Errors and Collection Errors 2011-2013). 
 Unlike Blood Bank, Laboratory blood specimen-labeling error data is not separated into 
the same categories (near miss and collection).  On average, 88 blood specimen-labeling errors 
are noted by Laboratory each month (Communication from Laboratory Medical Director, August 
2014) (see Appendix C - Laboratory Specimen Labeling Errors Jan. 2013 to June 2013).  Time to 
correct an error was estimated at a minimum of one and a half hours (30-40 minutes Laboratory 
personnel and one hour for Nursing personnel).   
 Errors in labeling specimens have never been an accepted practice but the magnitude of 
the problem was never fully appreciated until implementation of an EMR and LIS.  With WBIT 
occurrences increasing, Transfusion Medicine led the way in insisting on improvement measures 
in specimen labeling, knowing the risk of a wrong blood transfusion and associated morbidity 
and mortality.  Additionally, a clinical nurse specialist assigned as a category manager for the 
incident report system for blood transfusion alerted senior nursing leadership to the details of the 
mislabeling problem, prompting the nursing leadership into action.   
Intended Improvement/Purpose of Change 
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 The goal of this project was to reduce specimen-labeling error by replacing the manual 
specimen collection workflow, which included the necessity of printing labels and a paper 
requisition for each test at a central station and providing in its place a system for positive patient 
identification through barcoding and order matching.  Plans had been in place to implement a 
SCMS for several years.  However, due to limitations in technology, in the Laboratory and prior 
to an EMR, the project was placed on hold.  The project was re-ignited when the increase in the 
medical center’s WBIT errors were brought to light, as patient safety is paramount for the 
organization.  Implementation of a SCMS is not widespread in health care due to cost and 
complexity but has shown impressive results in specimen labeling error reduction (Morrison et 
al., 2010).   
 In 2001, “The Institute of Medicine issued a report, Crossing the Quality Chasm:  A New 
Health System for the 21st Century, which outlines six overarching “Aims for Improvement” for 
health care:  
   Safe: Avoid injuries to patients from the care that is intended to help them. 
   Effective: Match care to science; avoid overuse of ineffective care and underuse 
of effective care. 
   Patient-Centered: Honor the individual and respect choice. 
   Timely: Reduce waiting for both patients and those who give care. 
   Efficient: Reduce waste. 
 Equitable: Close racial and ethnic gaps in health status.” (IHI, 2014, p. 1). 
Based on the overarching aims for healthcare, the AIM statement for this project is to reduce 
specimen-labeling errors in blood specimens drawn in acute and critical care by 50% in nine 
months.  The new SCMS technology and specimen labeling workflow was piloted on one acute 
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care adult unit and one acute care pediatric unit to determine if the technology, workflow, and 
education of staff was operational and effective in reducing blood specimen labeling errors. 
Review of the Evidence 
 Prior to implementing an error reduction strategy for specimen labeling, it is important to 
examine the evidence nationally and internationally, asking the question “What strategies reduce 
blood specimen labeling errors in acute care/critical care settings?” A comprehensive literature 
search of PubMed, CINAHL, and EMBASE was conducted, followed by an analysis of the 
words contained in the titles and abstracts of the published studies, as well as the index terms 
used to describe the article.  Reference lists of all studies were searched for additional studies not 
previously identified.  Only English language studies from 2000 to 2014 were considered for 
inclusion.  Of note, the literature search did not surface any randomized controlled studies (see 
Appendix D – Evidence Table:  Specimen Labeling Error). 
 Cottrell et al. (2013) “conducted a systematic review addressing the issue of WBIT” (p. 
197).  Nine studies were eligible for inclusion and no randomized controlled trials were eligible 
(p. 199).  The investigators found the incidence of WBIT was studied extensively, with a finding 
of WBIT in 1:1,500 to 1:3,000 samples.  After a thorough review, all interventions to reduce 
WBIT were successful to some degree and multiple interventions over time were more likely to 
sustain a reduction in WBIT, though the duration of the reduction was unclear.  Positive patient 
identification, “zero tolerance” policies, education, weekly feedback, second check of ID, and 
electronic transfusion systems were found to be effective, individually and/or in combination 
(Cottrell et al., 2013). 
 A one-year prospective study conducted by Elhence et al. (2012) in the Department of 
Transfusion Medicine at a large tertiary academic medical center in India tracked all near-miss 
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and adverse events in the transfusion process and found that of the 285 transfusion related 
events, 271 (95%) were near-miss events.  Of those events, 53% were patient sampling errors, 
labeling errors, blood component handling errors, and storage errors.  Nine of these errors 
resulted in WBIT and were associated with collection of two or more samples from the same 
ward (Elhence, Shenoy, Verma, & Sachan, 2012).    
 An extensive analysis of laboratory event reports in 30 health care organizations studied 
by Syndman et al. (2014) found that “pre-analytic laboratory events were the most common 
(81%); the top three were specimen not labeled (18.7%), specimen mislabeled (16.3%), and 
improper collection (13.2%)” (p. 147).  The author further notes that “clinical laboratories 
contribute to nearly 23% of all reported errors”, contributing to unnecessary patient harm and 
cost (p. 147). 
 As far back as 2003, Dzik et al. and the Biomedical Excellence for Safer Transfusion 
(BEST) Working Party of the International Society for Blood Transfusion were investigating 
mislabeled and miss collected blood samples.  Eighty-two facilities located in 10 countries 
participated in a collaborative three-month study to identify and report mislabeled specimens, 
WBIT, and other collection errors.  The authors report that the “rate of mislabeled and miss 
collected specimens was 1,000 to 10,000 fold more frequent than the risk of a viral infection” 
(Dzik et al., 2003, p. 40). 
 Valenstein et al. (2006) went on to conduct a Q-Probes Study with 120 clinical 
laboratories to further understand error rates, adverse patient outcomes, and factors associated 
with lower error rates and better detection of errors.  The investigators found that identification 
errors were common.  “Participants from 120 institutions submitted information about a total of 
6,705 identification errors.  Of these, 5,731 (85%) of errors were detected before results were 
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released by the laboratory and 974 (14.5%) were detected after results were released” (p. 1109).  
Grimm et al. (2010) conducted a similar study to Valenstein utilizing a Q-Probe analysis of 122 
clinical laboratories but focused on mislabeling and WBIT samples.  “A total of 112,112 sample 
labels were reviewed and 1,258 mislabeled samples were identified for an overall mislabeled 
sample rate of 1.12% or 1 in 89 samples” (p. 1114).  “The rates of mislabeled samples and WBIT 
for United States participants were comparable to those reported in European countries” (p. 
1108).   
 A prospective study by Tondon et al. (2010) conducted at a 740-bed hospital blood center 
from January 2007 to June 2008 found error rates similar to those reported in previously noted 
studies.  Additionally, the Tondon study identified two key circumstances related to mislabeling; 
(1) multiple blood samples from same ward, and (2) failure to label at the bedside (p. 311).  In 
examining root causes for error, the findings regarding WBIT errors occurring when multiple 
samples are obtained from one ward were similar to the findings in the study conducted by 
Elhence in India. 
 Dunn and Moga (2010) conducted an extensive qualitative analysis at the Veterans 
Health Administration of 227 root cause analysis reports, from March 2000 to March 2008, to 
identify vulnerabilities in specimen collection, processing, analysis, and reporting associated 
with patient misidentification (p. 244).  Their findings prompted the following recommendations 
for improved safety and reduced error:  Wireless barcode technology at the bedside to confirm 
patient identity and to label a specimen immediately with a barcode label; barcode technology 
for the blood transfusion process; using of unique patient identifiers; automating laboratory 
forms; eliminate re-labeling in laboratory; making centralized phlebotomy continuously 
available; and eliminating paper labels in the operating room (p. 255).  When these 
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recommendations are linked with an updated laboratory information system, the turnaround time 
for reporting results is reduced.  After implementation of many of this study’s recommendations, 
the SLIP team found similar results preliminarily with regard to a reduced turnaround time for 
Laboratory at the medical center.  Though the study was conducted from 2000 to 2008 and 
published in 2010, many of the recommendations are still not in place in most institutions, 
demonstrating an unfortunate lag between evidence of best practice and implementation.  
 Standard quality improvement measures have demonstrated some success in reducing 
specimen-labeling errors, although the error rate is not zero.  A study by Wagar et al. (2006) 
utilized longitudinal statistical tools to analyze and trend patient safety implementation projects. 
The study found that 24/7 phlebotomy service, electronic event reporting, and automated 
processing contributed to decreased patient identification errors.  The investigators also note, that 
“Specific elements that contribute to success are sometimes difficult to identify in a longitudinal 
analysis schematic”(p. 1668).   
 Dzik et al. (2008) found that application of a simple statistical process control (SPC) was 
a useful tool to monitor critical processes and could be applied to specimen collection and 
labeling.  The SPC tool was adapted by 10 hospitals across five countries over a two-year period.  
A similar SPC tool is utilized at the medical center for tracking with results shared with 
managers.  The tool is useful for process tracking but has not proven to be effective in reducing 
error or changing practice behavior. 
 Education has been noted in the literature to have a positive impact on reducing specimen 
labeling and collection errors.  Bolenius et al. (2013) found that phlebotomists had poor 
adherence to blood specimen collection guidelines.  In that study, phlebotomists were divided 
into an intervention group (n=84) (received education) and a control group (n=79).  “The 
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educational program included three parts:  guideline studies, an oral presentation, and an 
examination.  Improvements were noted in the intervention group after education” (p. 1).   
 Strict policies whereby blood banks reject any mislabeled specimens or specimens with 
error are documented in the literature to be of some success in reducing error.  One such study 
from O’Neill et al. (2009) supports these findings.  In their retrospective study, the investigators 
studied the “combined effect of an educational campaign with strict enforcement of a specimen-
labeling policy by all clinical laboratories on the incidence of mislabeled and WBIT specimens 
detected in blood bank” (p. 165).  The intervention demonstrated a 73.5% (0.034% to 0.009%; 
p<= .0001) WBIT reduction and an 84.6% (0.026% to 0.004%; P<= .0001) reduction in 
mislabeled specimens (p. 164).   
 The emergency department at the medical center is one of the areas with the greatest 
number of mislabeled specimens and WBIT errors.  A pre-post intervention study by Hill et al. 
(2010) demonstrates that pairing of an electronic physician ordering system combined with 
barcode patient identification and barcoded specimen labels in an emergency department does 
reduce labeling errors.  A 74% relative and 31% absolute decrease in labeling errors was noted 
(p. 630).  Continued error was attributed to instances where physician order entry and/or barcode 
identification was not used.  Brown et al. (2011) noted that utilization of this same technology 
reduced labeling errors from 103 to 8 per year (p. 1).    
 A study by Morrison et al. (2010) confirmed positive outcomes with use of a barcode 
identification system combined with automated label printing, but found recurrent errors related 
to the lack of physician order integration, where paper requisitions were relied upon.  Mismatch 
of requisitions and blood tubes were the primary errors noted.  This is somewhat surprising, 
given that the study group encompassed only a small group of phlebotomists.  Even when a 
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clinician has only one task, human error plays a role.  Even more troubling, a study by Snyder et 
al. (2010) found that barcode identification systems are not foolproof.  Malfunctioning and 
poorly maintained barcode printers can introduce error in to the system via erroneous barcode 
labels and/or identification wristbands.  The investigators strongly recommend industry 
standards to address equipment functioning and quality.   
 Anasari and Szallasi (2011) investigated the use of a two-clinician patient identification 
check and a change in nursing policy regarding phlebotomy and found marginal improvement. 
The authors did not conduct a statistical analysis of their results.  The study further highlights the 
need for blood bank to “exhaust all resources in preventing” error (p. 301).  In 2006, the 
American Association of Blood Banks (AABB) began requiring two “independently drawn” 
specimens pre-transfusion for any patient not previously type and cross-matched by a facility (p. 
300).  In 2009 at their institution, the authors implemented the two-specimen intervention.  
Shortly thereafter, phlebotomists began altering the workflow process by drawing two specimens 
from a patient at the same time.  We have had similar issues at the medical center. 
 Reduction of human error and diffusion of innovation are concepts highlighted in the 
evidence as critical factors in designing an error free system for specimen labeling.  A 
combination of technology, system design, strict policies and education can reduce error.  More 
research is needed to obtain zero error rates in blood specimen labeling. 
Conceptual/Theoretical Framework 
 Theoretical and conceptual frameworks provide a guide for translating science into 
practice.  According to White and Brown (2012) a systematic approach to the translation of new 
knowledge into practice, guided by a framework or model, will increase the chances of a 
successful implementation (p. 25).  A conceptual framework, (The Swiss-Cheese Model of 
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Human Error by James Reason) and a theory, (Diffusion of Innovations by Everett Rogers) were 
utilized as frameworks for implementation of the innovative point of care specimen labeling 
system (SCMS).   
 In 1990, James Reason, professor of psychology at University of Manchester, proposed 
that human error could be approached from a person perspective or a system perspective.  The 
person approach has historically asserted that errors arose from poor mental processes such as 
carelessness, negligence, forgetfulness, inattention and lack of motivation.  A systems approach 
assumes humans are imperfect and errors will occur but are a consequence of system issues or a 
breakdown in “defenses” such as alarms, warning systems and poorly designed processes.  The 
defenses are equated to layers of Swiss cheese with holes that open and close.  A breakdown in 
one layer of cheese (hole) would not generally cause a bad outcome but if multiple layers of 
cheese holes aligned simultaneously, a major error is likely (Reason, 2000).  Reason further 
categorizes these breakdowns as two distinct types of failures:  active and latent.  Active failures 
are those errors committed by front-line operators and include such things as not following 
policy and procedure, omitting an important step in a process, or ignoring a warning signal.  
Latent failures are present in a system before a recognizable error or failure and lie dormant until 
a combination of factors ignite their presence.  All systems have a certain number of latent 
failure points and the goal is not to eliminate all factors but to identify and neutralize.  Error can 
be introduced into a system at all levels and at any time.  According to Reason, “Error proneness 
and the capacities for being stressed, failing to perceive hazards, being ignorant of the system, 
and having less than ideal motivation are brought by each individual to the workplace” (Reason, 
1990, p. 479).  Furthermore, according to Rasmussen (1983), people have three levels of 
performance:  (1) skill-based errors (action made is not what was intended); (2) rule-based 
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mistakes (action intended did not achieve intended outcome); and (3) knowledge-based mistakes 
(actions are intended but did not achieve outcome due to knowledge deficits) (p. 259).  
 Understanding Reason’s conceptual framework as it relates to latent failure points in a 
system, knowing these latent failure points contribute to the current labeling process error rate, 
and incorporating the science of human factors engineering provides a framework for addressing 
blood specimen labeling errors at the medical center.  The goals of human factors in health care 
are to support the health care professional in their work and to promote safe, quality care (Russ et 
al., 2013, p. 802).  Human factors science is “about designing systems that are resilient to 
unanticipated events and modifying the design of the system to better aid people” (Russ et al., 
2013, p. 803) and to address the levels of performance noted by Rasmussen.  In addition, 
according to Russ et al. (2013) stand-alone trainings are generally a weak intervention, but 
designing training programs after evaluating the workflow supports safety.  The SLIP project 
team took a systems and human factors approach in designing the SCMS implementation.  The 
team conducted a failure modes, effects, and critical analysis (FMECA) to understand system 
vulnerabilities and potential latent failure points.  It developed potential strategies to mitigate 
identified vulnerabilities while designing simulation training and workflow processes prior to 
implementation of the SCMS with staff involvement.  The SCMS eliminates at least four failure 
points from the current manual labeling process.  However, error reduction will only be 
accomplished if the new innovative technology is adopted throughout the organization. 
 Once the implementation plan was developed, the SLIP project team focused on 
innovation adoption, best framed through Everett Roger’s (1962) theory on Diffusion of 
Innovations.  Rogers, a professor of communication studies, theorized that diffusion of an 
innovation (perceived as new) occurs through communication channels among members of a 
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social system over time.  Wide adoption of an innovation must occur in order for the adoption to 
self-sustain and there is a point where the rate of adoption reaches a critical mass.  Rogers 
conceived of five categories of adopters:  innovators, early adopters, early majority, late 
majority, and laggards” (Rogers, 1962, p. 150).  Further, he claimed that each individual 
experiences five stages of accepting an innovation:  knowledge, persuasion, decision, 
implementation, and confirmation.  During the decision stage, the individual decides whether to 
adopt or reject the innovation.  Adoption is an individual process, whereas diffusion is a group 
process and social systems determine norms on diffusion.  Additionally, certain specific 
characteristics of innovations influence adoption:  relative advantage, compatibility, complexity 
or simplicity, trial ability, and observability (Rogers, 2004). 
 Implementation of SCMS technology and process were directed toward reconfiguring the 
value chain for patients by reducing specimen label errors.  The patient is unlikely to notice the 
change in process but will benefit from avoiding the necessity of additional phlebotomy due to a 
labeling error.  Error reduction also saves clinicians time through decreases in follow-up and lab 
re-draws, not to mention reduced turnaround time for laboratory test results.  Highlighting 
benefits to patients and staff encourages adoption to new workflows.   
 Nurses in acute and critical care were introduced to and trained on SCMS.  Unit-based 
nursing champions (early adopters) were identified and received additional training on SCMS, 
allowing them to support their peers with the new technology and process and to communicate 
any issues to the project team.  This approach is a cultural norm and has been used successfully 
in numerous large initiatives at the medical center.  Simulation training (highly regarded) and 
staff involvement with the FMECA and project planning contributed to effective communication 
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about the new process and its optimization.  The sole competitor was the previous paper-based 
process known by all clinicians.   
Methods 
Ethical Issues 
 The goal of the SLIP project was to implement a quality improvement process and meet 
the University of San Francisco’s (USF) definition of quality improvement (as defined by The 
Institute of Medicine): “a systematic pattern of actions that is constantly optimizing productivity, 
communication, and value within an organization in order to achieve the aim of measuring the 
attributes, properties, and characteristics of a product/service in the context of the expectations 
and needs of customers and users of that product” (USF DNP Department Policy, 2014, p.9).  On 
September 23, 2013 USF determined that the project met the guidelines for an Evidence-based 
Change in Practice Project as outlined in the Doctor of Nursing Practice Project Checklist (see 
Appendix –E- Student Project Approval:  Statement of Determination).  There are no identifiable 
ethical issues or conflicts of interest noted for this project. 
Setting 
 The SLIP project was conducted at a 700+ bed academic medical center on the West 
Coast.  The medical center is known for providing care to patients with highly complex medical 
and surgical diagnoses.  The academic medical center is undergoing a major transformation as 
evidenced by a new vision, name, and newly developed strategic plan (2014-2019) that will 
guide the organization in delivering on their mission.  Implementation of an innovation in 
specimen labeling, which enhances safety and care delivery, is consistent with mission, vision 
and values and strategic plan of the organization.  The medical center’s vision is to provide 
innovative, high-quality, cost-competitive clinical services, and to deliver unparalleled patient 
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experience across the entire continuum.  Strategic goals, being a leader in destination programs, 
promoting a high valued system, and achieving a culture of continuous process improvement all 
further define how the organization will live its mission.  Utilizing these directional strategies 
provides stakeholders with their purpose and alignment.  
For acute care patients, phlebotomists work with specimens obtained from a direct stick 
to the patient.  Registered nurses (RN) obtain all blood specimens in critical care and line draws 
in acute care.  Prior to implementation of the SCMS, acute care staff labeled their specimens 
after collecting the specimen and critical care staff labeled beforehand.  Phlebotomy is not a core 
skill for RNs and has been loosely coupled with the Laboratory.  Blood specimen labeling errors, 
primarily an issue with RN phlebotomy, had been identified by the medical director of Blood 
Bank and the medical director of Laboratory as a serious safety issue over several years. The 
director’s approach of sharing data with managers proved ineffective in reducing blood specimen 
labeling errors.  Senior nursing leaders did not fully appreciate the issue at the time.  
Implementation of an EMR further highlighted the problem.  Potential for error abounded with 
mismatched specimen labels, requisitions and patients.  Systemic issues could not be corrected at 
the local level.  Subsequent implementation of a LIS for Laboratory provided the necessary 
software and integration of systems for utilizing technology to address the specimen labeling 
issue.  
Planning the Intervention 
  Plans were developed for implementation of the SCMS to integrate order entry with 
patient identification and specimen labeling at the point of care (see Appendix – F – SCMS 
Concept).  Initially, SCMS was to roll out across all inpatient settings and in the Emergency 
Department at the medical center.  However, having identified complexities of SCMS early on, 
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the SLIP project team determined that a smaller scale implementation would yield a higher rate 
of success and that further implementation of SCMS could be accomplished at a later time.  The 
goal of this project was to reduce specimen label errors by replacing the existing manual 
specimen collection workflow with an innovative, integrated technology, SCMS.  Patient safety 
is a primary objective of the medical center and implementing a new collection management 
system for blood specimens addresses the need for improved workflow and reduced labeling 
errors. 
Objectives 
1. Utilize current barcode scanning equipment and EMR for SCMS; 
2. Train staff on SCMS processes by utilizing a simulation training approach; 
3. Implement SCMS on two pilot units, with spread to adult/pediatric acute and critical care 
units.  
Initially, SCMS was to roll out across all inpatient settings and emergency department at the 
medical center.  However, having identified complexities of the SCMS early on, the SLIP project 
team determined that a smaller scale implementation would yield a higher rate of success and 
further implementation of SCMS could be accomplished at a later time.  Emergency Department, 
Mother/Baby, and Perioperative Services all have higher labeling error rates than acute and 
critical care and also have dissimilar and complex workflows that need further analysis prior to 
SCMS implementation.    
Laboratory purchased 150 wireless label printers in anticipation of implementing SCMS.  
As part of the EMR plan the medical center had already installed barcode scanners at every 
inpatient bedside for medication administration along with a computer workstation.  An early 
version of label printers had been tested on a handful of units several years prior and failed 
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miserably.  At the time, there was no EMR with order integration and barcode scanners had not 
been installed.  Achieving a better result required thoughtful planning.  This project was multi-
faceted and required a significant amount of support from IT, dedicated time to conduct a 
FMECA and streamline workflow, resources to educate/train staff, and time for policy revisions.     
 A nurse informatics project manager and Laboratory Services manager, was assigned to 
the SLIP project as well as an information technology (IT) project manager.  These three leaders 
coordinated logistics and drove the project.  The Associate Chief Nursing Officer 
(ACNO)/Doctor of Nursing Practice (DNP) student took administrative lead of the project and 
partnered with the Patient Safety manager.  The Chief Nursing Officer (CNO)/Executive 
Director of Patient Care Services covered executive sponsorship.  The Chief Medical Officer 
offered, as a resource, a GE Six Sigma/Lean consultant to assist with data management and to 
provide structure using six sigma and Lean tools.  A staff nurse was added to the SLIP team. 
Staff involvement is a key to success in most of our projects, as staff brings valuable insight to 
workflows and processes that are not apparent to those not practicing at the bedside.  An 
educator was assigned to develop simulation scenarios and assist with initial training.  The listed 
roles comprised the core SLIP team.  Additional stakeholders, including staff were included on 
an ad hoc basis (see Appendix – G – Stakeholder, Role, Responsibility and Communication 
Matrix).     
Effective communication was essential with a project of this magnitude both with the 
project team as well as with external customers such as clinicians, providers, and managers.  A 
weekly project team meeting was held to review deliverables, issues, changes, risks and 
decisions.  Development of a SharePoint site facilitated daily updates and communication within 
the team.  Unit-based super-users provided local staff support.  
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The ACNO/DNP student explored the literature for evidence-based approaches to 
correcting specimen labeling errors and to better understand the problem on a global level.  
Evidence in the literature indicates that the SCMS approach has achieved the best results in 
reducing specimen-labeling errors.  Focus and commitment from Laboratory, Blood Bank, IT, 
and executive leadership provided a platform for success in moving forward with this project.  
Staff has embraced bedside technology and historically, when they are included in project 
planning/implementation, they have engaged in supporting project success.   
 A business case was compiled to determine the best option going forward. 
Options 
 Option #1 Maintain Current System:  The specimen labeling system was paper-based and 
did not interface with the EMR.  Specimen labels were printed at a central station in batches.  
Nurses would obtain laboratory requisitions from one printer at the central station and labels 
from another printer.  There were many opportunities for mismatching labels, requisitions and 
specimens.  Patient identification at the point of care for obtaining specimens was inconsistent.  
The medical center has approximately 50-100 (88 average) specimen labeling errors per month 
in Laboratory and another 88/month in Blood Bank at a cost of $125.00 each.  Patient safety is 
compromised with potential for a life-threatening event due to a mislabeled specimen or WBIT.  
Laboratory turnaround times are slowed down when error occurs and clinician time is increased 
due to the need to address an error. 
 Option #2 The Preferred Solution:  Implement SCMS across the adult, pediatric acute 
and critical care areas.  SCMS integrates patient identification, provider order, and laboratory 
specimen identification through barcode technology and interfaces with the EMR at the point of 
care.  Nurses will use this technology as a safer process for specimen labeling. 
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 Option #3 Alternative:  Implement SCMS on a limited basis to selected inpatient areas.  
Training costs account for a large portion of the expense of this project.  Limiting the areas 
where SCMS is utilized reduces training costs.  However, two standards of specimen labeling 
would exist, potentially leading to confusion, inconsistency, and non-standard workflows for 
nurses, phlebotomists, and laboratory technicians processing specimens in the laboratory.  
Standard specimen labeling processes with integration in the EMR reduces opportunity for error.   
A cost/benefit analysis of the three options was completed (see Appendix–H- Cost/Benefit 
Analysis).  Maintaining the current labeling process was the most expensive option, noting that 
every error could result in a potential lawsuit.  Options #1 and #3 did not meet the objectives of 
improving safety and reducing error.  Option #2 cost had an equal benefit within a year, 
primarily due to cost avoidance.  An even greater benefit noted if multiple lawsuits were 
avoided.     
 The project team’s decision, supported by the executive sponsor and Laboratory 
collaborative sponsors, to move forward with Option #2 in a phased approach:  acute and critical 
care (adults and pediatrics) phase one, Emergency Department and Mother/Baby in phase two, 
and Perioperative Services and Respiratory Therapy in phase three.  One adult and one pediatric 
acute care unit piloted the new SCMS for one month to assess for workflow issues, equipment 
issues and to optimize processes prior to further rollout.  A project charter was developed by the 
SLIP team to further define the project scope and deliverables (see Appendix – I – Project 
Charter). 
 The SLIP team (plus ad hoc group) conducted a FMECA from January to March 2014 
prior to finalizing education and simulation training as a proactive risk assessment to determine 
failure modes in the specimen labeling process using SCMS as a new system.  Identified 
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vulnerabilities would be mitigated, if possible, prior to implementation.  The FMECA was 
presented to Patient Safety Committee and approved.  An education plan was developed that 
included training unit-based super-users for local support of staff and trouble shooting issues, as 
well as training pilot unit staff in SCMS.  Initially, the plan for education had been a one-hour 
classroom training.  However, that quickly evolved (after FMECA results) to a two-hour 
simulation training, including a module on specimen labeling errors and a video showcasing the 
path of a specimen through the Laboratory (See Appendix –J- Training Module).  In addition, 
further investigation of safe practices by a staff member of the SLIP team uncovered a process 
called Final Check that verbalizes a final check of the last three digits of the medical record 
number. All involved in the FMECA supported incorporating Final Check into the SCMS 
process. 
“In May of 2011, Palmetto Health Richland Hospital in Columbia, South Carolina and 
the South Carolina Hospital Association partnered with Outcome Engenuity in a project 
to demonstrate a rapid reduction in the number of mislabeled blood specimens. The goal 
was to achieve a 90% drop in mislabeled specimens (the wrong patient’s label on a blood 
specimen) in a 90-day time frame. The project was intended to be a broader 
demonstration of the power of Just Culture concepts to dramatically reduce the rate of 
adverse patient safety events. The project was met with immediate success at Palmetto 
Health. As a second phase, the South Carolina Hospital Association recruited five 
additional hospitals to implement The Final Check in an attempt to validate its 
universality. As with Palmetto Health Richland, five additional hospitals showed a 90% 
reduction in mislabeled specimens in the first month after implementation, improving to a 
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93% reduction after three months. The success has been sustained for five months thus 
far, as of June 2012” (Final Check, n.d., p. 1). 
Implementation of the Project 
 Back-end IT infrastructure to support implementation of SCMS was performed in 2012 
and was part of a separate capital budget project.  Barcode scanners were installed with EMR 
implementation in 2012.  Equipment installation for SCMS began in January of 2014 by 
Facilities and IT.  This entailed installation of brackets to hold label printers, mobile carts, and 
testing of wireless connectivity with the label printers.  Connectivity issues were immediately 
identified; IT attempted to remedy, but without success.  The Informatics nurse determined that 
an adaptive approach was needed.  Cables were purchased to wire the wireless label printers to 
in-room computers.  Acute care units have fewer laboratory orders requiring nurse phlebotomy; 
therefore, each acute care unit has three or four portable label printers to use with specimen 
collection.  The SLIP project training for super-users and staff (pilot units) began in March, 
conducted by an educator and project managers from Informatics and Laboratory.  Education 
was well received.  Staff commented that they felt prepared to use SCMS on their units and had a 
better understanding of specimen management and the importance of labeling correctly.  Process 
compliance monitoring began immediately, with data collected by Laboratory and observation 
from nurse managers. The SLIP team was interested in whether staff were using the new system 
or continuing to use the old paper-based system.  Observations revealed staff was using the new 
Final Check process in addition to the labeling system.  Over the course of the pilot month, 
compliance rose to 90% as more staff was trained on pilot units.   Workflows were adjusted 
based on staff feedback and new discoveries with the SCMS functionality.  After a successful 
pilot series, further training and rollout of SCMS occurred across all of the acute care units, 
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following the same optimized model.  A workflow assessment of critical care was conducted and 
simulation training adjusted accordingly.  Critical care staff was trained and SCMS implemented.  
Compliance monitoring was incorporated.  A draft specimen labeling policy/procedure was 
written with input from SLIP team members, Laboratory medical director, and reviewed by staff 
to ensure the document reflected practice (See Appendix –K- Specimen Labeling Policy). 
Feedback from staff and Laboratory was evaluated to determine if there were further 
training needs and/or equipment and workflow issues had surfaced.  Super-users provided onsite 
unit support to staff and were able to answer numerous questions.  IT intervened on equipment 
issues.  The staff nurse working with the SLIP team provided training for staff returning from 
leave of absence and those new to the organization.  Training for new hires will be incorporated 
into new hire orientation.     
Planning the Study of the Intervention 
 Regular debriefing on project implementation was essential to assessing a successful 
implementation and to inform improvements for phases two and three.  An overall approach of 
Plan, Do, Study, Act (PDSA) drove the project through to completion in phase one and will be 
used for subsequent phases.  The project began in October 2013 with an initial meeting of key 
stakeholders from the project team, Laboratory, Blood Bank, IT, Facilities, Performance 
Improvement, and Nursing Education.  In November 2013, the design was completed and later 
enhanced after the FMECA was completed.  Training began in March with the pilot units 
utilizing SCMS by April 2014.  (See Appendices L and M- Gantt Chart and Training and 
Implementation on SCMS).  Numerous improvements were made on the pilot units prior to 
broader rollout.  As an example, labeled specimen tubes began arriving in the Laboratory with 
labels that were offline.  Laboratory personnel were convinced the nursing staff was mislabeling.  
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However, on investigation, the team discovered that the labels were not properly inserted in the 
label printers.  Loading labels into printers was incorporated into training.   
 Staff was asked to complete a Survey Monkey to provide feedback on satisfaction with 
the new system and training, as well as to report any challenges.  One comment nicely sums up 
the system “when all the technical aspects are functioning properly, it is a highly efficient 
process.  The workflow does take some getting used to, however, once settled, it’s safe and quick 
and I can use my time for other patient concerns”  (See Appendix –N- Survey Monkey Tool).  
Laboratory and Blood Bank continued to send specimen labeling error data.  The SLIP team 
extracted the units using SCMS to determine improvements/error reduction.  The Laboratory 
manager involved in the project provided feedback from the Laboratory’s perspective.  The 
FMECA process informed educational planning for simulation training (workflows and potential 
failure points) and identified equipment adjustments required prior to implementation.  Steps in 
the FMECA process included: 
• Steps in the process of using SCMS (bedside procedure or handheld portable Dolphin) 
• Potential failure modes 
• Potential causes of failure 
• Effects of the failure 
• Ranking severity, probability of failure effect and detection 
• Calculating criticality to rank order potential failure modes and prioritize remedial efforts 
• Potential solutions and outcome measures 
(See Appendices – O and P– Failure Mode, Effects and Critical Analysis (FMECA) Summary 
and Workflow Analysis). 
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 Project details were carried out by the IT project manager, Informatics nurse and 
Laboratory manager, all with strong project management skills.  Installation of brackets, ordering 
additional label printers, cables and labels, and assisting the educator with staff training 
comprised some of their project duties.  Facilities, Clinical Engineering, and IT ensured 
equipment was ready for use across 15 units.  Once the equipment was in place, training and 
follow-up were key items going forward, with approximately 1800 nurses to be trained.  Nurse 
managers were accountable for staff following the new labeling process.  The ACNO/DNP 
student granted approval for financial resources to order equipment and find rooms for training 
when the simulation lab was unavailable.  The Patient Safety Manager and ACNO/DNP student 
co-presented the project to the Patient Safety Committee and other interdisciplinary forums to 
communicate the change process.    
 Primary objectives were achieved and the organization gained valuable insights about the 
risks associated with specimen collection and labeling.  Timeline challenges were ongoing.  
Labor disputes and competing priorities necessitated adjusting schedules.  Discussions of 
risks/benefits of delaying training and/or implementation were frequent and acknowledged that 
the primary desired outcome was a robust, accurate labeling process.  Baseline data 
demonstrated the need for improvement (See Appendices – A, B and C - Blood Bank Specimen 
Labeling Errors and Laboratory Specimen Labeling Errors 2011-2013).   
Methods of Evaluation 
 Instruments used for evaluation were multifactorial.  Laboratory specimen labeling error 
data collection was in place prior to SCMS implementation and continued after implementation.  
The GE consultant collaborated with Performance Improvement to extract from the data set 
those units using SCMS to measure improvement.  The LIS vendor-developed Survey Monkey 
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to staff, collected information on satisfaction and challenges with the training and process (See 
Appendix –N - Survey Monkey).  An observation tool developed by the SLIP staff nurse 
representative provided a mechanism for observing practice and measuring process (See 
Appendix – Q-Observation Tool).  Measurement of staff compliance with using SCMS is tracked 
through a manual process in the Laboratory and provided to the GE consultant for analysis. 
Other metrics and data analysis for specimen labeling are still in development.  Patient days were 
used for a denominator to determine labeling error rates.  In September, new software installed in 
Laboratory will enable counting of samples (denominator).  Further discussion with Performance 
Improvement is necessary in order to determine ongoing process measures, frequency of 
measurement, and reporting structures.  Only labeling error measurements were provided by 
Laboratory prior to SCMS. 
A strengths, weaknesses, opportunities and threats analysis (SWOT) was used to 
determine risk and feasibility of this project (see Appendix – R – SWOT Analysis).  Resources 
are stretched for IT-related projects, which must compete with EMR updates, optimization, 
report requests, and the ongoing construction of a new facility at a new campus location. 
However, laboratory orders touch every patient and any error poses significant risk for adverse 
outcomes. 
 Project expenses and return on investment (ROI) were determined in a financial analysis 
compiled by the ACNO/DNP student.  Budget for SCMS implementation consisted primarily of 
training expense, with an estimated 3,644 hours (2 hours/nurse x 1,527 nurses).  Staff backfill 
time was unnecessary, as other staff on duty could provide care delivery during training.  Staff 
direct-labor expense was calculated at $65.00/hour and indirect labor expense at 30%, totaling 
$85.50/hour.  Licensing and acquisition of SCMS software occurred through Laboratory and was 
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integrated into the EMR by IT through a separate capital expenditure.  Additional expenses 
incurred included funds for printers, cables, power strips, and wiring.  Project managers, GE 
consultant, and educator were included in budget projections.  The nurse’s home unit absorbed 
staff nurse participation time on the SLIP team.  Project sponsors were not included as expenses, 
given that this type of project is a portion of their daily work.  ROI occurs after 48 months based 
on an assumption that labeling errors are eliminated and cost avoidance produces a savings.  
SCMS does not generate revenue.  Further cost avoidance from lawsuits are possible but not 
captured in budget projections (see Appendix – S – Budgetary Return on Investment Plan 
(ROI)).    
 SCMS implementation in critical care surfaced workflow issues not apparent in acute 
care.  Volume of laboratory orders, physician practices in critical care and EMR design imposed 
unexpected challenges.  A critical care focus group of staff, IT, and Laboratory was designated to 
meet weekly and work through and resolve issues.  Avoiding development of a workflow 
breakdown was paramount to quickly resolving workflow problems.   
Analysis 
 Both quantitative and qualitative data were collected from participants to evaluate 
process, satisfaction, error rates, and problems with the new system.  Survey Monkey software 
was used for an online survey and Laboratory information system was used to note labeling 
errors and Laboratory turnaround time.  Patient days were used as a proxy denominator for 
number of specimen samples.  Data analysis is a work in progress with the SLIP project.  More 
time is needed to trend data and hardwire new processes and workflows, continually monitoring 
for unintended latent failure points.  
Results 
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Program Evaluation/Outcomes 
 The medical center is a complex, somewhat chaotic organization, that despite 
environmental and system challenges, delivers extraordinary care.  Standardization of processes 
has not been emphasized historically.  Leadership realizes the lack of standardization creates a 
vulnerability.  The evidence in the literature is clear:  standardization enhances patient safety.  In 
addition, once the medical center as a whole is aware of a safety issue, there is an impetus to 
correct the problem.  Therefore, over the past several years, the focus has been on setting in place 
standard processes and workflows.  Reason’s work makes it apparent that any system will have 
latent failure points that need to be recognized and monitored.  Lack of standard workflows 
creates difficulty in tracking failure points.    
 Staff response to SCMS has, for the most part, been positive.  Equipment and EMR 
workflows are continually under revision and are the greatest sources of complaint.  As a result 
of feedback on inconsistent equipment and supply availability, the Unit Coordinators were 
enlisted to conduct daily checks of necessary items (See Appendix – T –Unit Coordinator 
Checklist).  The Laboratory Medical Director and Blood Bank Medical Director are both pleased 
and anxious for SCMS to be implemented across the organization.  Senior leadership is impatient 
with project length, had to be reminded of previous decisions that slowed progress.  Quality 
leaders desire full implementation as soon as possible.    
As with many projects, no one had any idea the magnitude this project would entail in 
terms of length, required resources, and impact prior to the FMECA and phase one 
implementation.  Initially, the idea was to use existing technology (barcode scanners and bedside 
computers), then add label printers at the bedside to improve patient identification and specimen 
labeling.  During the course of the project, questions arose regarding EMR workflow and 
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Laboratory interface in general, but those were not within the scope of this project.  The initial 
improvement plan evolved over time, as previously noted, driven by several factors, including 
new knowledge (FMECA), labor disputes (slowed timeline), IT connectivity (slowed timeline), 
adjustment in required equipment (wireless label printers an adaptive model), competing 
priorities for project managers, and competition for training space.  The SLIP team and medical 
center leadership mitigated all of these challenges for phase one.  The enthusiasm of all 
participants was of great help in moving the project forward, as was team communications to 
others in the organization.  The simulation training provided a positive and informative 
approach, not only regarding SCMS but also in regard to human factors error.  Development of a 
process audit plan with a schedule for all units and managers is still needed and is under 
consideration.   
Despite numerous challenges, implementation of SCMS has been dramatically successful 
in reducing blood specimen labeling errors, although compliance with using the system is 
currently at approximately 50%.  Once fully implemented across the medical center, it will 
represent a significant step toward ensuring patient safety.  Early results are positive.  As noted, 
more data collection and analysis is needed (See Appendices U, V, W, X and Y – Training 
Compliance, Efficacy of SCMS with Blood Bank, Efficacy of SCMS with Lab, Laboratory 
Labeling Errors After SCMS, and Laboratory Reported Labeling Errors).  Laboratory turnaround 
time data is not presented due to the need for further analysis.  Pressure is mounting to complete 
phases two and three of SLIP, which will include Emergency Department, Mother-Baby and 
Perioperative areas.  However, the medical center is preparing for a new campus and facility; 
resources are stretched.  The SLIP team recommended to senior leadership of Laboratory and 
Nursing to wait on phase two and three until the campus transition is complete.  Risks of waiting 
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include ongoing safety issues with specimen labeling in high-risk areas and the possibility that 
the project will not reinvigorate for phase two and three.  The benefits of waiting include an 
opportunity to re-focus, ability to study workflows in complex settings before implementing, and 
time to install equipment with testing prior to implementation.  Leadership made the final 
decision to wait until the new campus transition was complete.  In the meantime, the medical 
director of Laboratory and members of the SLIP team will contact other organizations that have 
implemented SCMS and use the same EMR, to exchange information.  The team hopes to glean 
insight for those issues identified in phase one and to better prepare for phase two and three 
implementation. 
Discussion 
Summary 
Implementation of SCMS was successful for several reasons:  (1) the system and process 
reduced RN time for specimen collection; (2) it provided a streamlined workflow; (3) it 
improved safety for patients; (4) it led to a reduction in both labeling error and Laboratory turn-
around time (preliminary data).  Two factors contributing to the success of implementation were:  
(1) conducting a FMECA to understand workflows and failure points prior to education 
programming, and (2) incorporating staff on the SLIP team and in workgroups.  Role-play 
simulation training was somewhat new for the medical center.  It has proven to be a powerful 
tool in demonstrating to staff the full scope of a process, highlighting potential failure points and 
providing feedback to staff after return demonstrations.  Role-play simulation training was 
utilized with barcode medication administration; data analysis shows a 95% barcode compliance 
rate for patient identification and medication identification.  Translating medication 
administration processes to blood specimen collection processes may have contributed to early 
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success.  Unit-based super-users have been, and continue to be with this project, successful 
models for the medical center, supporting staff when they need it.  Ongoing leadership will be 
necessary to sustain error-labeling reductions, including regular review of data at quality 
meetings.  Holding staff accountable to use SCMS is another critical factor.  In an emergency, 
paper requisitions may be used for blood specimens.  Unfortunately, some staff has continued to 
use paper requisitions in non-emergent situations.  Laboratory is considering increased 
restrictions and will not accept paper requisitions for non-emergent specimens.  Development of 
a process audit plan with a schedule for all units and managers is necessary and will be 
developed in the next month.   
Advanced practice nurses prepared in systems thinking, integrated with quality and 
performance, are essential for projects such as SLIP.  The gap between evidence and practice 
continues, but as more nurses are prepared in advanced roles, that gap should narrow.  It is 
unclear whether the project managers would have facilitated a FMECA or enhanced simulation 
training without influence of the ACNO/DNP student and Patient Safety Manager.  Further, this 
project highlights the need for flexibility from the micro to macro levels.   
Relation to Other Evidence 
 The SLIP project results appear to be similar to findings from other organizations that 
implemented a SCMS type system.  Results are not directly comparable; the sample denominator 
is needed from Laboratory.  However, internal pre/post improvement is evident and comparable.  
Other organizations report strict processes and policies, but also note potential breakdown in 
workflow processes.  Observation and direct feedback to staff after implementation are 
interventions known to improve processes and outcomes.  The SLIP team is committed to 
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conducting periodic observations and following up with managers to ensure hardwiring of the 
new system. 
Barrier to Implementation/Limitations 
Studying the SCMS process uncovered issues with connectivity and equipment, 
physician orders, workflow and integration with Laboratory processes. A few issues were 
anticipated and a few were not anticipated.  Some of these workflow issues have impact on RNs, 
particularly in critical care, and are under investigation for improvement solutions.  Equipment 
functionality has been the biggest concern for acute care, specifically regarding wireless printers 
that did not have adequate and consistent connectivity.  An adaptive model was implemented.  
RNs obtained a label printer from a central unit location and then plugged the printer into the 
computer in the patient room.  Ports have become worn and damaged with plugging and 
unplugging.  Further investigation of alternatives for an adaptive model is underway.   
Sometimes when an organization has a heavy focus on outcome data, the process to 
achieve those outcomes may cover other issues that might thwart safety.  An example is the 
expectation to use barcode medication administration.  The SLIP team found that the nurse 
determination to use a barcode scanner potentially introduces error.  If the barcode scanner is not 
functioning properly at the patient bedside and troubleshooting does not result in a functioning 
scanner, the nurse is likely to go to another room to use that scanner.  When identification and 
labeling do not occur at the point of care, safety is compromised.  Greater focus on equipment 
maintenance was an outcome of this project.   
 The greatest challenge for the SLIP project team has been resources to train (including 
space limitations), progression to implementation, data analysis, and full evaluation.  Although 
this project was a collaborative effort between Nursing and Laboratory, most of the project has 
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been led by Nursing.  This makes sense for training and unit implementation, but not necessarily 
in terms of accountability for data analysis and accountability for ongoing resources to 
disseminate SCMS across the medical center.  Unforeseen labor disputes and IT issues disrupted 
original timelines and these changes had a consequence to the project, as resources were pulled 
to other planned implementations.  Competing priorities are a known operational balancing act.  
Phase two and three will be implemented at a later date. 
Interpretation 
 Units that have implemented SCMS have reduced levels of specimen labeling errors.  
Standardizing workflow, identifying patients, integrating physician orders electronically through 
the EMR, and labeling specimens at the point of care all contributed to reducing errors in 
specimen labeling.  While eliminating breakdowns in system processes and maintaining strict 
adherence to policies is difficult, both are essential to sustaining improvement.  Regular 
measurement and data presentation, holding leaders accountable for outcomes, and gathering 
feedback from nurses regarding barriers to improvement will all support sustaining the gain.   
Until there is accurate sample data (denominator), comparable data to outside organizations is 
forthcoming.  Pre/post results are dramatic but trending is needed.  The SLIP team expected 
significant improvement but knew that until all staff had been trained on SCMS and was using 
the system, data would not reflect the full impact of SCMS.  Discontinuation of paper 
requisitions is needed to force function staff to use SCMS.     
Improvement projects such as SLIP are equivalent to peeling an onion with many layers.  
The project team acknowledges that until a workflow analysis is completed for any given area, it 
is nearly impossible to anticipate failure points.  Phase two and three units have high volume 
Laboratory orders and complex workflows.  The experience of completing phase one SCMS, 
SPECIMEN LABELING IMPROVEMENT PROJECT:  SLIP 42 
 
informed the decision to study workflows in phase two and phase three areas prior to 
implementation.  Other opportunities for improvement with Laboratory specimen ordering and 
collection have surfaced.  Though they were not within scope for this project, they have been 
brought to the attention of and key leaders.  As mentioned previously, SLIP team members and 
Laboratory medical director will be contacting other organizations for their expertise.  
Conclusions 
 Systems approaches and technology, combined with human factor science, are absolutely 
necessary for error reduction and patient safety.  Unfortunately, equipment manufacturers and 
organizations often do not incorporate these strategies to reduce error and the burden is left to 
those directly delivering care to patients.  In addition, a change in one system impacts other 
systems and produces unanticipated consequences.  Thoughtful plans, resources, 
implementation, and evaluation are necessary for success.  If appropriate quality measures are 
not instituted on the front end of a project, the time to course correct after implementation is 
large.  Specifically, more research is needed regarding what, on the surface; seem to be 
straightforward processes, such as labeling a specimen.  Implementation of SCMS has reduced 
specimen-labeling errors and will be more broadly installed in coming months.  Even with the 
new system and technology, error is not eliminated nor does it approximate six-sigma. The 
medical center is moving toward technology as a strategy to improve systems, reduce 
redundancy, improve safety and improve efficiency.  A systematic review of each service 
interface would likely highlight those processes needing improvement, which is preferable to 
waiting for an untoward event to surface the problem. 
Other Information 
Funding 
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        Funding for the SLIP project occurred over several years (implementation of EMR, barcode 
scanners, LIS), under capital funding.  One hundred fifty wireless label printers were purchased 
by Laboratory.  Additional equipment, installation needs, and staff time to participate and be 
trained in the project was absorbed into Nursing Administration cost center.  Nursing maintains 
project and discretionary funds for projects that are not fully funded or need support.   
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Appendix A 
 
Blood Bank Specimen Labeling Errors 2011 to 2013 
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Appendix B 
 
Blood Bank Specimen Collection Errors 2011 to 2013 
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Appendix C 
 
Laboratory Specimen Labeling Errors January 2013 to June 2013 
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Appendix D 
Evidence Table:  Specimen Labeling Error 
 
STUDY METHOD SAMPLE INTERVENTION OUTCOMES / RECOMMENDATIONS 
STRENGTH 
OF 
EVIDENCE 
I-V 
QUALITY 
OF 
EVIDENCE 
A-C 
Anasari & 
Szallasi 
2011 
Retrospective 
qualitative 
study 
N=59,373 
(26 WBIT) 
Incidence of wrong blood in 
tube (WBIT) over 4 years 
(WBIT) represents leading 
cause of potential mis-
transfusions.  Two specimens 
and policy impact some 
labeling errors but more safety 
measures needed 
III C 
Bolenius et 
al.   
2013 
Quasi-
experimental 
study 
N=84 
N=79 
Pre/post questionnaire after 
education 
Some improvement but not 
significant II B 
Brown et al. 
2011 
Pre/post 
intervention 
study 
N=103 
errors/yr 
Implementation of specimen 
collection/labeling system 
with barcode technology and 
label printers 
Decrease from 103 labeling 
errors to 8/year (p<.001) III B 
Dunn & 
Moga 
2010 
Qualitative 
study 
N=227 root 
cause analysis 
reports 
Qualitative analysis of 227 
root cause analysis reports 
from Veterans Health Admin. 
Pre-analytic phase errors 
accounted for 182 out of 253 
patient misidentification errors 
III B 
 
Dzik et al. 
2003 
 
Qualitative 
study 
N=71 
hospitals 
completed 
questionnaires 
N=62 
hospitals 
submitted data 
N=690,000 
samples 
Hospitals in 10 countries 
reported mislabeled and mis-
collected sample data 
Study concludes mislabeled 
and mis-collected samples rate 
is 1000-10,000 (1 in 165 
samples) more frequent than 
risk of viral infection from 
blood  
III B 
Dzik et al. 
2008 
Non-
experimental 
longitudinal 
study 
10 hospitals in 
5 countries 
Applied statistical process 
control charts tabulating the 
frequency of mislabeled and 
mis-collected blood samples 
over 2 years 
Participating hospitals found 
the SPC tool helpful in 
monitoring specimen labeling 
error reduction progress 
III B 
Elhence et 
al. 
2012 
Non-
experimental 
longitudinal 
study 
N=285 
transfusion 
related events 
from 2009 to 
2010 
Prospective study in India to 
record, classify and analyze 
near miss and adverse events 
 53% were near miss events 
that occurred at bedside III B 
Grimm et 
al. 
2010 
Prospective 
study 
N=122 
institutions 
Each institution reviewed inpt 
and outpt ABO samples for 
labeling errors 
All institutions combined had a 
mislabeled sample rate of 
1.12% 
III B 
Henneman 
et al.   
2010 
Prospective 
observational 
study 
N=28 nurses, 
16 techs, 17 
ED assoc. 
Simulated patient scenarios 
with eye-tracking device 
Wide variation among health 
care workers in verifying 
patient id 
III B 
Hill et al.  
2010 
Pre/post 
intervention 
study 
Pre 
N=724,465 
Post 
N=334,039 
Physician order entry and 
barcode id 
Combination of Physician 
order entry and barcode reduce 
Emergency Dept. specimen 
labeling errors (31%) with 95% 
confidence 
III A 
Kim et al.  
2012 
Retrospective 
analysis 
study 
N=9072 
Standardized process-driven 
id and specimen labeling 
protocol 
Decrease of 5.79 events/1000 
to 3.53/1000 III C 
Morrison et 
al.   
2010 
Pre/post 
intervention 
study 
Pre 
N=181,758 
Post 
N=184,043 
specimens 
Barcode patient identification 
and label printers, training 
43% reduction in mislabeled 
samples 
38% reduction in unlabeled 
samples 
III A 
O’Neill et 
al.  2009 
Pre/post 
intervention 
study 
 
Pre 
N=106,174 
Post 
N=104,860 
specimens 
Education and strict policy 
adherence 
73.5% reduction in WBIT 
errors 
(0.034% to 0.009%; p<.0001) 
III B 
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STUDY METHOD SAMPLE INTERVENTION OUTCOMES / RECOMMENDATIONS 
STRENGTH 
OF 
EVIDENCE 
I-V 
QUALITY 
OF 
EVIDENCE 
A-C 
Rees et al. 
2012 
Pre/post 
intervention 
N=197 
specimen 
identification 
events 
Four areas of focus; 
establishing clear 
expectations of staff, 
education, process (system) 
review and feedback 
Post interventions an 85% error 
reduction in specimen label 
errors 
III C 
Snyder et 
al. 
2010 
Quasi-
experimental 
study 
N=10 
defective 
barcodes 
N=225 
scans/barcode 
Re-scans conducted by 3 
operators, 15 times each, 
using 5 different scanner 
models 
As many as 3 incorrect patient 
identifiers generated from 
single defective barcode 
II B 
Snydman et 
al. 
2012 
Qualitative 
study 
N=37,532 
laboratory 
event reports 
from 30 health 
care orgs 
Cross-sectional analysis of 30 
organizations of reported 
laboratory events in US 
Pre-analytic laboratory events 
were the most common 
(81.1%) 
III B 
Tondon et 
al. 
2010 
Prospective 
study 
N=32,189 
recipient 
samples 
N=22,794 
donor samples 
Prospective study to report 
distribution, type and 
frequency of errors through 
blood bank 
Total of 342 errors (6.2/1000 
samples) with 87.1% clerical 
and 86.5% outside of blood 
bank 
III B 
Valenstein 
et al.  2006 
Q-probes 
analysis 
study 
N=120 
institutions 
Compilation of lab patient id 
errors over 120 institutions 
Most errors are detected before 
results released (85%) 
III B 
Vuk et al. 
2014 
Non-
experimental 
longitudinal 
study 
N=955,218 
blood 
donations 
collected over 
12 year study 
period (2002-
2013) 
Longitudinal study of WBIT 
frequency in donor samples in 
Croatia 
WBIT error rate was 34 
(0.0018%).  Potential causes 
multifactorial and controllable 
III B 
Wagar et al.  
2006 
Non-
experimental 
longitudinal 
study 
N=16,632 
total specimen 
errors 
2003-2005 
24/7 phlebotomy service, 
electronic event recording, 
automated processing 
Implementation of patient 
safety measures reduces 
specimen-labeling errors.  1230 
total errors/month reduced to 
555/month 
III B 
 
Level 1 = Experimental study/randomized controlled trial (RCT) or meta-analysis of RCT 
Level II = Quasi-experimental study 
Level III = Non-experimental study, qualitative study, or meta-synthesis 
Level IV = Opinion of nationally recognized experts based on research evidence or expert consensus panel (systematic 
review, clinical practice guidelines) 
Level V = Opinion of individual expert based on non-research evidence.  (Includes case studies; literature review; 
organizational experience eg. Quality improvement and financial data; clinical expertise, or personal experience) 
 
A = High  Research—consistent results with sufficient sample size 
                 Summative Reviews—well-defined, reproducible search strategies 
      Organizational—well-defined methods using a rigorous approach 
      Expert Opinion—Expertise has been clearly evident  
 
B = Good  Research—reasonably consistent results, sufficient sample size 
                  Summative Reviews—reasonably thorough and appropriate search 
       Organizational—well-defined methods 
       Expert Opinion—expertise has been clearly evident 
 
C = Low Quality or Major Flaws  Research—little evidence with inconsistent results, insufficient sample 
                                               Summative Reviews—undefined, or poorly defined methods 
                         Organizational—adequate reliability or validity 
                                    Expert Opinion—expertise has not been discernable   
 
Newhouse, R., Dearholt, S., Poe, S., Pugh, LC., White, K., Johns Hopkins Evidence-Based Practice Appraisal. 
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Appendix E 
 
Student Project Approval:  Statement of Determination 
 
University of San Francisco 
School of Nursing and Health Professions 
Student Project Approval:  
Statement of Determination                                                                                                                
Title of Project:  Develop a strategy to reduce pre-transfusion blood specimen labeling errors at the point of 
care in a hospital setting. 
 
Brief Description of Project:  Pre-transfusion blood sample labeling errors increase the risk of transfusion-
associated patient morbidity and mortality and continue to be a significant risk in hospital settings in the US 
and internationally.  According to the literature, pre-transfusion blood specimen labeling errors present a 
greater risk than the safety of the blood and error reduction may be reduced through education, policies, and 
barcode technology.   
Baseline error data will be collected including blood transfusion specimen label errors and wrong blood in 
tube errors (WBIT) across all inpatient units.  Utilizing process mapping to understand current process, 
review of current policies, and thorough literature review for evidence based practices, and introduction of 
barcode technology as an improvement strategy.  Lean methodologies will be utilized to reduce process waste 
and engage staff in process improvement solutions. 
Post improvement data will be collected on a unit-by-unit basis and a root cause review of each error as a 
means to further understand and improve the process.     
 
 
 
 
 
 
To qualify as an Evidence-based Change in Practice Project, rather than a Research Project, the criteria outlined in 
federal guidelines will be used:  (http://answers.hhs.gov/ohrp/categories/1569)  
X   This project meets the guidelines for an Evidence-based Change in Practice Project as outlined in the Project 
Checklist (attached). Student may proceed with implementation. 
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This project involves research with human subjects and must be submitted for IRB approval before project 
activity can commence. 
Comments:   
 
Signature of  Supervising Faculty__________                                                    (date)             
Signature of  Student                                                                                               (date)         
EVIDENCE-BASED CHANGE OF PRACTICE PROJECT CHECKLIST * 
 
STUDENT NAME: Traci Hoiting DATE:  September 23, 2013  . 
 
SUPERVISING FACULTY:  K T Waxman. 
 
Instructions: Answer YES or NO to each of the following statements: 
Project Title:  
 
YES NO 
The aim of the project is to improve the process or delivery of care with 
established/ accepted standards, or to implement evidence-based change. There is 
no intention of using the data for research purposes. 
X  
The specific aim is to improve performance on a specific service or program and is 
a part of usual care.  ALL participants will receive standard of care. 
X  
The project is NOT designed to follow a research design, e.g., hypothesis testing 
or group comparison, randomization, control groups, prospective comparison 
groups, cross-sectional, case control). The project does NOT follow a protocol that 
overrides clinical decision-making. 
 X 
The project involves implementation of established and tested quality standards 
and/or systematic monitoring, assessment or evaluation of the organization to 
ensure that existing quality standards are being met. The project does NOT 
develop paradigms or untested methods or new untested standards. 
X  
The project involves implementation of care practices and interventions that are 
consensus-based or evidence-based. The project does NOT seek to test an 
intervention that is beyond current science and experience. 
X  
The project is conducted by staff where the project will take place and involves 
staff who are working at an agency that has an agreement with USF SONHP. 
X  
The project has NO funding from federal agencies or research-focused 
organizations and is not receiving funding for implementation research. 
X  
The agency or clinical practice unit agrees that this is a project that will be 
implemented to improve the process or delivery of care, i.e., not a personal 
research project that is dependent upon the voluntary participation of colleagues, 
students and/ or patients. 
X  
If there is an intent to, or possibility of publishing your work, you and supervising 
faculty and the agency oversight committee are comfortable with the following 
statement in your methods section:  “This project was undertaken as an Evidence-
based change of practice project at X hospital or agency and as such was not 
formally supervised by the Institutional Review Board.”  
X  
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ANSWER KEY: If the answer to ALL of these items is yes, the project can be considered an Evidence-based 
activity that does NOT meet the definition of research.  IRB review is not required.  Keep a copy of this checklist 
in your files.  If the answer to ANY of these questions is NO, you must submit for IRB approval. 
 
*Adapted with permission of Elizabeth L. Hohmann, MD, Director and Chair, Partners Human Research 
Committee,  Partners Health System,  Boston, MA.   
 
 
 
THIS TABLE PROVIDES AN OVERVIEW OF THE DIFFERENCE BETWEEN RESEARCH AND QUALITY 
OR PROCESS IMPROVEMENT 
 
 RESEARCH QI/PROCESS IMPROVEMENT 
DEFINITION “A systematic investigation, including 
research development, testing and 
evaluation, designed to develop or 
contribute to generalizable knowledge. 
Activities, which meet this definition, 
constitute research for purposes of this 
policy, whether or not they are 
conducted or supported under a 
program, which is considered research 
for other purposes. For example, some 
demonstration and service programs 
may include research activities.” 
http://www.hhs.gov/ohrp/humansubject
s/guidance/45cfr46.html#46.102 
 
Assess or improve a process, program or 
system to improve performance as judged 
by the evidence, i.e., established/ accepted 
standards 
PURPOSE Answer a question or test a hypothesis Improve performance/ process or systems 
 
BENEFITS May or may not benefit current 
patients, but may benefit future patients 
Directly benefits a process, program or 
system and may or may not directly benefit 
patients 
 
RISKS May put subjects at risk Does not increase risk to patients with 
exception of possible privacy/ 
confidentiality concerns 
 
DATA 
COLLECTION 
Systematic data collection Systematic data collection 
 
DATA  
ANALYSIS 
Statistically prove or disprove 
hypothesis 
Compare a program/ process/ system to an 
established set of standards 
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Appendix F 
 
SCMS Concept 
 
 

SCMS	
DesignPoints
State	of	the	Art	Technology	
• PortableEquipment
• Interfaceswith
ElectronicMedical
Record
• BarcodeTechnology
• Interfaceswith
LaboratorySystem
• PointofCare
Technology
• ReducesErrors

Functional:	Equipment,	specimen	tubes,	laboratory	
order,	labels,	and	patient	identification	all	in	one	
place	
Emotional:		The	organization	cares	about	my	
patients	and	me	
Social:		Safety	for	Patient-Centered	Care	
	
Customer	Benefits	
Product	concept	
TargetCustomer(s)
Product
UseCases
ProblemstoBeSolved
NursingStaff
Safety:Patient,laborder,specimen
identification
Regulatory:Labelatpointofcare
Efficiency:Nopaperrequisitions
Pointofcarespecimenlabeling
technology
Labelingerrorsduetomislabeled
specimensandmisidentifiedpatients
Decentralizedspecimencollection
process
Multiplestepstoassemblesupplies
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Appendix G 
 
Stakeholder, Role, Responsibility and Communication Matrix 
 
Stakeholder Role Responsibilities Communication 
CNO Executive 
Sponsor 
Approves budget, 
resources, point of 
escalation for issues that 
can’t be resolved within 
SLIP team 
Communication to senior 
executives on project 
progression/issues 
Medical Directors, 
Laboratory and 
Transfusion 
Medicine 
Collaborative 
Oversight of 
SLIP Project 
Removing barriers during 
project implementation 
Communication to 
Medical Staff Quality 
Committees 
ACNO/DNP 
Student 
Project Sponsor-
Nursing 
Approves scope, FMEA 
co-lead, training time, 
budget for training, 
escalation of issues 
Communication to 
Nursing 
Directors/Managers 
Patient Safety 
Manager 
Project Sponsor-
Patient Safety 
FMEA co-lead, chairs 
SLIP project team, 
represents Quality 
Management Team 
Liaison to Quality 
Management and Patient 
Safety 
Informatics Nurse Project Lead-
Nursing 
Purchase of equipment, 
coordinator of project, and 
training, super-user 
competency sign-off 
Project Update 
Communication 
Laboratory 
Services Manager 
Project Lead-
Laboratory 
Services 
Laboratory Services 
configuration, training, 
SCMS expert 
Liaison to Laboratory 
Management Leadership 
Information 
Technology 
Project Manager 
IT Systems 
Management 
Coordinate all IT 
interfaces, SCMS vendor 
interface and wiring 
Liaison to IT Leadership 
GE Consultant GE Six 
Sigma/Lean 
Consultant 
Incorporating Lean and Six 
Sigma concepts into 
project, data analysis 
Liaison to Performance 
Improvement  
Staff Nurse Project 
Assistance 
Policy review, workflow 
review, training, 
observation survey 
development, general 
troubleshooting 
Liaison to Staff and 
within SLIP Team 
Educator Simulation 
Educator 
Development of simulation 
scenarios and training 
Liaison with Nursing 
Excellence 
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Appendix H 
 
Cost/Benefit Analysis 
 
Cost/Benefit Analysis 
Category Details Cost in First 
Year 
Option # 1 
No change 
Cost of error correction:  Personnel 
time=$125/error x 729 errors (1 year, 
2013) 
Cost of potential lawsuit:  $500,000 
(history of 1 lawsuit related to mislabeled 
specimen) 
$91,125 cost of 
errors:  BB & 
Lab 
$500,000 cost 
of one lawsuit 
 
Total  $591,125 
Option # 2 
Phased 
approach 
Phase 1 equipment and training acute 
care/CC care (adults and peds) 
Phase 2 and 3 ED, Mother-Baby, Periop 
$354,563 
 
$ 100,000 
Total  $454,563 
Option # 3 
Only complete 
Phase 1 
Only do Phase 1 $354,563 
Total $354,563 
Benefits 
Benefit Benefit Within 
12 Months 
Avoid potential lawsuit related to specimen labeling $500,000 x 1 
($500,000 x 
729 actual 
errors = 
$364,500,000) 
potential 
expense from 
lawsuits 
50% reduction in specimen labeling errors in 9 months 
(personnel time) 
$45,563.00 
Patient satisfaction $50,000 
Total 
Potential Expense if Each Error Resulted in a Lawsuit 
$595,563 
($364,595,562) 
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Appendix I 
 
Specimen Labeling Improvement Project Charter 
 
Project Objective Scope 
• Reduce specimen labeling error by 
replacing current manual specimen 
collection workflow including the necessity 
to print a paper requisition for each test and 
labels at a central station and to provide 
positive patient identification with barcoded 
patient identification and order matching to 
enhance specimen collection processes.   
In Scope: 
• Phase 1: Inpatient Nursing Units 
(adults/pediatrics) 
• Phase 2:  ED and Mother/Baby 
• Phase 3:  Perioperative areas, 
Respiratory Therapy collected 
specimens,  
• Lab Tests:  All order types, blood 
specimens for clinical lab/Blood 
Bank 
 
Out of Scope:   
• Special procedural areas, 
Outpatient locations, non-blood 
specimens 
Deliverables Information Technology 
 
• Technical go-live for pilot unit:  03/01/14 
• Pilot go-live for 2 nursing units:  03/31/14 
• FMEA:  January to March 2014 
• Additional unit go-live:  TBD 
• Training materials reflect continuity from 
Computer Provider Order Entry (CPOE) 
order entry to SCMS Registered Nurse (RN) 
workflow using computers, scanning 
devices, and specimen label printers 
• Completion of training is mandatory for 
inpatient RN staff 
 
• Procurement/deployment of 
wireless and wired label specimen 
printers to patient care areas 
• Customer Service Support 
provided by IT 
• Backend infrastructure built and 
supported by IT 
• SCMS application deployed to all 
patient care computers 
 
 
     Success Criteria 
 • Utilization by end-users 70% after 
one month 
• Patient identification with 
barcoding and order matching 
>90% after one month 
• Mislabel reduction by 50% after 
nine months for acute/critical care 
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Appendix J 
 
SLIP Training Module 
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SPECIMEN LABELING IMPROVEMENT PROJECT:  SLIP 67 
 
 
 
 
SPECIMEN LABELING IMPROVEMENT PROJECT:  SLIP 68 
 
 
 
 
 
 
SPECIMEN LABELING IMPROVEMENT PROJECT:  SLIP 69 
 
 
 
 
SPECIMEN LABELING IMPROVEMENT PROJECT:  SLIP 70 
 
 
 
 
 
SPECIMEN LABELING IMPROVEMENT PROJECT:  SLIP 71 
 
 
 
 
 
SPECIMEN LABELING IMPROVEMENT PROJECT:  SLIP 72 
 
 
 
 
 
 
 
SPECIMEN LABELING IMPROVEMENT PROJECT:  SLIP 73 
 
 
 
 
SPECIMEN LABELING IMPROVEMENT PROJECT:  SLIP 74 
 
Appendix K 
 
Specimen Labeling Policy 
 
Office of Origin: Department of Patient Safety 
 
I. PURPOSE 
 
To enhance patient safety by providing a consistent method for correct 
identification of inpatient and outpatient specimens. 
 
II. REFERENCES 
 
The Joint Commission National Patient Safety Goals 
 
The Joint Commission Laboratory Accreditation Manual, Standard 
QC.2.20 Laboratory Manual for MEDICAL CENTER Clinical 
Laboratories 
Administrative policy 2.1.1 Patient Identification  
 
Department of Pathology Specimen Receipt, Identification, and Rejection Policy 
 
III. DEFINITIONS 
 
Not applicable. 
 
IV. POLICY 
 
For all specimens taken from patients for clinical testing or received in a 
laboratory setting from within or outside of Medical Center, the person 
collecting or receiving the specimen must verify the correct specimen and 
correct patient by comparing two unique identifiers to one or more source 
documents, such as the order for the lab test, or other appropriate paperwork, 
and labels for the specimen. 
 
The two identifiers are the patient’s name and medical record number. If for 
some reason the specimen must be/has been collected before a patient has been 
registered or if the specimen is from a source outside of Medical Center, the 
patient’s name and birth date may be used as the patient identifiers. 
 
This policy applies whether a specimen is sent to the laboratory for processing 
or is used for a point-of-care laboratory test. 
 
V. PROCEDURES 
 
A. Collecting specimens 
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1. Refer to the MEDICAL CENTER and MEDICAL CENTER 
SATELLITE Clinical Laboratories Manual, the MEDICAL CENTER 
Pont- of-Care Testing Manual, and department-specific procedures for 
test-specific information related to how to collect and send a specimen. 
 
2. Prior to obtaining the specimen, assure proper patient identification by 
comparing two patient identifiers provided by the patient or from the 
patient ID wristband (inpatient) per Patient Identification 
Administrative Policy 2.1.1 to the order(s) or paper requisition(s).  If 
using a manual process (e.g. a system other than Specimen Collection 
Management System) assure printed specimen labels match two patient 
identifiers and the patient information on the requisition.  For 
specimens, such as urine, stool, sputum, collected by the patient, apply 
an addressograph/Epic patient label to the specimen container prior to 
giving it to the patient.  Departments using Specimen Collection 
Management System will attach a Specimen Collection Management 
System generated label to the container after the specimen has been 
obtained. 
3. If the order or paperwork (labels and paper requisition) and one or more 
of the identifiers do not match, do not collect the specimen. Obtain 
correct patient or correct paperwork and repeat patient verification 
process. If unable to verify, notify the appropriate provider who 
ordered the test. 
 
B. Labeling Specimens 
 
1. For specimens being sent to the main Clinical Laboratory using a  
requisition it must include, at a minimum, the following: 
 
ii. patient’s first and last name 
 
iii. patient’s sex and date of birth 
 
iv. Medical Record number 
 
v. patient location 
 
vi. ordering physician name and identification number (ambulatory patients) 
 
vii. applicable ICD-9 code(s) (ambulatory patients) 
 
viii. tests to be performed 
 
2. For specimens being sent to Pathology, the requisition must contain: 
 
ii. Patient’s first and last name 
 
iii. Medical record number and/or birth date 
 
iv. Location (hospital, clinic, private office) 
 
v. Date specimen obtained from patient 
 
vi. Attending/referring physician name 
 
vii. Specimen source/site 
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viii. Pre-op diagnosis,  ICD-code, or relevant history  
 
3. Specimen label: 
 
i. For Clinical Laboratory specimens labeled using Specimen 
Collection Management System labels are generated after 
collection of specimens and include patient first and last name, 
medical record number, date of birth, date collected, time 
collected and phlebotomist code and test to be run.   
 
ii. Specimens collected without Specimen Collection 
Management System MUST at a minimum include patient first 
and last name, medical record number or date of birth and date 
collected. 
 
1) For Clinical Laboratory samples, when preprinted labels from 
the Clinical Labs or Specimen Collection Management System 
are not available, use an addressograph/Epic label, or legibly print 
the patient’s first and last name, MEDICAL CENTER medical 
record number or date of birth and date and time of collection. 
 
 2) For Clinical Laboratory specimens collected for Blood Bank 
tests, including blood typing, and/or cross match, the 
addressograph/Epic label must include patient's full name, 
medical record number, date of birth, date/time drawn and person 
collecting sample information (written legibly) name (first and last) 
or code or if collected by a physician, physician ID number and 
name (first and last). Initials are NOT accepted.  
 
 3) For Pathology specimens, the site/source must be included if 
multiple sites are involved, in addition to name, medical 
record number and/or date of birth. 
 
4. Label every specimen obtained in the room or at the bedside of the 
patient except when the specimen is collected by the patient himself, 
such as urine or stool. In this case, label the container with an 
addressograph/Epic patient ID label prior to giving it to the patient.  
Departments using Specimen Collection Management System will 
attach a Specimen Collection Management System generated label to 
the container after the specimen has been obtained. 
 
5. Place only specimen(s) and any paperwork from only ONE patient in a 
bag for transport to the laboratory. Ensure that specimen(s) and 
paperwork in the bag are from the same patient. 
 
C. Labeling Specimens Removed During A Surgical Procedure 
 
1. The specimen label includes the patient identification information, the 
specimen source identification, and any other information required by 
laboratory policy. 
 
SPECIMEN LABELING IMPROVEMENT PROJECT:  SLIP 77 
 
2. Specimens are properly labeled in the room where they are collected; 
such sites include operating rooms, examination and treatment rooms 
in ambulatory practices, and any other area where specimens are 
obtained. 
 
3. For pathology specimens, the patient identification label should be 
affixed to the side of the specimen container, and not on the lid if at 
all possible. 
 
D. Receipt of Mislabeled and Unlabeled Specimens 
 
1. When the identification of a specimen submitted for analysis is in 
any way questionable, the laboratory will recommend that, if 
feasible, a new specimen should be obtained. 
 
2. If the laboratory is unable to determine from whom a specimen 
has been collected with a reasonable degree of certainty, a new 
specimen must be obtained. 
 
3. When there is a mismatch between the name on any paperwork and on 
the specimen (Mislabel) the specimen should in virtually all 
circumstances be recollected. In cases where a mislabeled specimen is 
irretrievable or where re- collection would jeopardize patient care (e.g. 
invasively collected samples, intra- operative samples, timed samples, 
etc.) AND the specimen itself can be  identified with reasonable 
certainly, exceptions to the above policy may be made. These decisions 
will be the responsibility of the Laboratory Medicine resident on duty or 
a Laboratory Director. In cases where the mislabeled specimen is 
approved for testing, the patient's physician must accept responsibility in 
writing for the specimen being processed. The test result in the patient's 
chart will carry the notation the sample was "REC'D 
MIS(UN)LABELED-RUN AT MD'S REQUEST and under some 
circumstances an entry may be made in the progress notes by laboratory 
staff further describing the relevant circumstances. 
 
4. The pathology department will make every effort to obtain the 
information needed to process the specimen; however, if they 
prove unsuccessful, the specimen will not be processed. 
 
VI. RESPONSIBILITY 
 
Questions about the implementation of this policy under routine circumstances 
should be directed to Patient Safety Department 555-1212. 
 
VII. HISTORY OF POLICY 
 
Separated from Patient Identification policy, April 
2002 Approved April 2002 by CEO 
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Revised July 2005 by Director, Regulatory Affairs Reviewed 
September 2005 by Policy Steering Committee 
Reviewed by Patient Care Director, Ambulatory Care Services 
 
Approved November 2005 by Executive Medical Board, Governance 
Advisory Committee 
 
Reviewed by Lab Standards Committee, January 
2010 Reviewed by Patient Safety Committee, 
February 2010 Reviewed by Policy Steering 
Committee, March 2010 Reviewed by Senior 
Leadership Group, March 2010 Reviewed by 
Patient Safety Committee May 2010 
Revised by Patient Safety Manager July 2014 
Reviewed by Patient Safety Committee July 2014 
Reviewed and approved by Policy Steering Committee September 2014 
 
 
This guideline is intended for use by Medical Center staff and personnel and no 
representations or warranties are made for outside use. Not for outside production or 
publication without permission. 
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Appendix L 
 
Gantt Chart 
 
Milestones 2013   2014         
 Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sept 
Initial 
Meeting 
10/1            
Design  11/10           
FMECA    1/6         
Training      3/1 
Pilot 
Units 
Acute 
Care 
Units 
  CC 
Unit  
  
Implement      3/30 
Pilot 
Units 
Acute 
Care 
Units 
  CC 
Unit 
  
Evaluation       4/1      
Phases 2 
& 3 TBD 
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Appendix M 
 
Training and Implementation Schedule on SCMS 
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Appendix N 
 
Survey Monkey Tool 
Initial Report 
Last Modified: 06/17/2014 
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SPECIMEN LABELING IMPROVEMENT PROJECT:  SLIP 84 
 
 
 
SPECIMEN LABELING IMPROVEMENT PROJECT:  SLIP 85 
 
Appendix O 
 
Failure Mode, Effect, and Criticality Analysis (FMECA) Summary 
 
Failure Mode, Effect, and Criticality Analysis (FMECA) – 2014 
Specimen Labeling Improvement Project Summary Report 
 
Aim:  During the process of blood specimen collection, errors in ordering, collection and 
labeling might occur that could potentially have adverse patient consequences.  This FMECA 
was done as a proactive risk assessment prior to initiation of SCMS, a new process for specimen 
labeling and requisitioning of a specimen order, to determine failure modes in the specimen 
labeling process using SCMS identify potential solutions.   
Team Lead:  ACNO/DNP Student and Patient Safety Manager 
Team:  SLIP and Ad Hoc  
Process:  The team met from January 2014 – March 2014 to complete the FMECA prior to 
initiation of training for SCMS. SCMS is a LIS application that is used to identify patients and 
print labels, which serve the dual purpose of label and requisition, at the patient’s bedside to 
eliminate the risk of specimen mislabeling and streamline specimen collection workflow.  The 
process used to complete the FMECA was to identify: 
• Steps in the process of using SCMS (bedside procedure or dolphin) 
• Potential failure modes 
• Potential causes of failure 
• Effects of the failure 
• Ranking severity, probability of failure effect and detection 
• Calculating criticality to rank order potential failure modes and effects importance 
• Potential solutions and outcome measures 
 
The FMECA was completed prior to initiation of training of super users and pilot unit staff that 
began the end of March.   
Failure Modes/Potential Vulnerabilities: 
Staff may not understand significance of proper technique, potential for error, risk of harm 
Solutions: 
a) Include pictures of specimens with improperly positioned labels 
b) Show how labels are read by machine 
c) Include stories from bedside about impact of mislabeled specimens 
d) Include discussion of cognitive bias as potential source of error 
 
There are a variety of references used by staff to determine what specimen container to use and 
the volume of specimen needed 
Solutions: 
a) Get rid of all reference material 
b) Add specimen container and volume criteria to EMR work list 
c)  Encourage use of lab manual for infrequently obtained specimens 
d) Pediatric units will need reference sheets as lab criteria defaults to adult references 
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Hunting and gathering of supplies adds distractions and time to specimen collection process 
Solutions: 
a) Standardize caddies 
b) Develop checklist for managers on assuring equipment is available 
 
There is a potential for equipment to not be available when needed which may result in staff 
defaulting to manual process 
Solutions: 
a) Establish standard work on maintenance of equipment and supplies 
b) Develop TIP sheets and FAQs about maintenance of printers and cables 
c) Encourage use of dedicated WOW for acute care units 
d) Encourage dedicated location for equipment/supplies on all units 
 
Equipment may not work properly 
Solutions: 
a) Develop troubleshooting guide 
b) Encourage managers to develop process for maintaining equipment and supplies 
 
There is a potential for staff to default to process steps that increase the risk for labeling error 
Solutions: 
a) Establish standard work to include  
1. Drawing specimen then labeling 
2. The person obtaining specimen is the person who creates label, or if not possible the 
person who obtains specimen prints name on label 
3. Final check of last 3 digits of MRN said out loud 
4. Limit the number of labels at the bedside 
5. Develop SCMS Procedure 
6. Develop RN blood draw policy 
 
Adoption of SCMS may be slow because it is a new workflow 
Solutions: 
a) Develop tip sheet for process, have accessible 
b) Develop reports on compliance with using SCMS vs. opting out for unit managers 
 
 
 
 
 
 
 
 
 
Appendix P 
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Workflow Analysis 
 
 The collection process was mapped in entirely and details 
 Too manual and paper work driven and dependent 
 Printing one place and use the labels in another place 
 Loose labels are floating around 
 Human Errors 
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Appendix Q 
Specimen Labeling Improvement Observation Tool 
Medical Center 
Specimen Collection Management System 
Specimen Collection Observation Form 
 
 
Location:______________________________   Date:____________________________ 
 
 
Name of Person Conducting Observation:______________________________________ 
 
 
 Action 
1 Requisition Printed (where, when, by whom?): 
 
 
 
2 Label Obtained (where, when, by whom?): 
 
 
 
3 Supplies Gathered (where, when?): 
 
 
 
4 Hand Hygiene: (where, when?, should be more than once): 
 
 
 
5 Identifies pt* (should compare name and MRN on armband to req): 
 
 
 
6 Assesses venipuncture site (tourniquet applied): 
 
 
 
7 Site preparation (cleansing technique): 
 
 
 
8 Aseptic technique during venipuncture: 
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9 Needle entry angle (between 15-30o): 
 
 
 
10 Draw Order (note order in which tube colors/types are drawn): 
 
 
11 Tubes filled and mixed (how full?, how mixed?): 
 
 
 
12 Needle care (safety device used, straight to sharps container?): 
 
 
 
13 Bandage applied (how, what): 
 
 
 
14 Labels applied: 
 
 
 
15 Second Pt ID*: 
 
 
 
16 Specimen Handling (which bag, how sent to lab?) 
 
 
 
 
    Additional    
Notes:_______________________________________________________________________________ 
_____________________________________________________________________________________
_____________________________________________________________________________________ 
   *Tip for patient identification: the current practice does not promote verbalizing this step. Therefore it 
is sometimes difficult to ascertain compliance while observing. It is often helpful after the observation to 
ask how and what the RN checked for patient ID. With medication observations, the answer is often name 
and birthdate, not MRN.  
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Appendix R 
SWOT Analysis 
 
Strengths 
• Excellent compliance with barcode 
scanning technology used for patient 
identification with medication 
administration 
• EMR with CPOE since 2012-integrates 
with SCMS 
• Evidenced-based technology for specimen 
label error reduction 
• Supports and in alignment with medical 
center’s strategic plan to improve patient 
safety 
Weaknesses 
• Medical center wireless capacity  
• Workflow change, requiring large 
scale educational support 
• Competing medical center priorities 
• Clinician recognition of error 
impact 
• Additional equipment to maintain, 
clean and track 
Opportunities 
• Improve patient safety by reducing blood 
specimen label error rates 
• Improve patient value chain 
• Reduce Laboratory turn-around time 
• Improve clinician satisfaction 
• Reduce waste and inefficiencies, leaving 
more time for care delivery  
Threats 
• IT system downtime 
• Clinician/phlebotomist adoption  
• Training expense 
• Equipment failure, tracking and 
cleaning 
• New technology may introduce new 
latent failures  
• Failure of previous label printers 
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Budget Return on Investment Plan (ROI)
 
 
Total 
Responses Mean 
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Appendix T 
Unit Coordinator Checklist 
Unit Coordinator SCMS rounding list: 
  
 In Patient Rooms: 
 Cables present 
 Cable works (plug printer in; if power = then cable intact) 
 Check that Lab Coll is active (simple icon check) 
 In Med/Supply Room:  
 Labels stocked 
 Label levels in printer adequate 
 Clean printers, inside and out 
 Power cables present and working 
 Monitor open tickets 
 Place tickets for IT issues found during rounds 
General IT fix-its: 
• Dead Wow: plug in wow; open back door on bottom; flip black switch; wait 30 
seconds; flip switch back) 
• Broken Scanner: check that bottom of scanner is tight 
White USB cable missing: look for black USB cable! 
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Appendix U 
Compliance and Utilization Analysis of SCMS 
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Appendix V 
Efficacy of New Process in Blood Bank 
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Appendix W 
Efficacy of New Process in Laboratory 
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Appendix X 
Laboratory Label Errors After SCMS 
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Appendix Y 
Laboratory Reported Label Errors After SCMS 
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